Skip to content
107 av. Victor Hugo, Paris 16th11 rue Lacépède, Paris 5th
Surgery and tests

Myomectomy or embolisation for a fibroid: how to choose?

By Dr Olivier Kadoch, obstetrician-gynaecologistReviewed on Next review: October 20277 min read

In brief

Fibroid embolisation (uterine artery embolisation, which blocks the vessels that supply the fibroid) and myomectomy (surgical removal of the fibroid) are the two main conservative treatments for symptomatic fibroids when a woman wishes to keep her uterus. In the British randomised FEMME trial (254 women, New England Journal of Medicine, 2020), fibroid-related quality of life at 2 years was better after myomectomy (score of 84.6 versus 80.0 out of 100). Embolisation, on the other hand, offers faster recovery and fewer transfusions, at the cost of a higher risk of further intervention: according to Cochrane, if 7% of women who have surgery need another procedure within 2 years, this rate is estimated at 15 to 32% after embolisation.

What do these two treatments involve?

Myomectomy is a surgical operation that removes the fibroid or fibroids while preserving the uterus. It is performed by hysteroscopy (fibroids within the cavity), laparoscopy or laparotomy depending on the position and size of the fibroids. It is carried out by a gynaecological surgeon, most often under general anaesthesia.

Uterine artery embolisation is performed by an interventional radiologist. Under local anaesthesia and sedation, a fine catheter is inserted into the femoral artery (in the groin) or the radial artery (at the wrist) and guided to the uterine arteries. Tiny particles are injected there to block the blood supply to the fibroids, which then necrose and gradually shrink. There is no incision and no scar on the uterus.

What does the FEMME trial show?

The FEMME trial, conducted in 29 British hospitals, is the largest randomised trial directly comparing the two treatments in women with symptomatic fibroids who did not want a hysterectomy.

Its main results at 2 years:

  • fibroid-related quality of life (UFS-QOL questionnaire, from 0 to 100): 84.6 after myomectomy versus 80.0 after embolisation, i.e. an adjusted difference of 6.5 to 8 points in favour of myomectomy;
  • complications across all initial procedures: 29% in the myomectomy group and 24% in the embolisation group.

This trial included myomectomies by laparotomy, laparoscopy and hysteroscopy, which reflects real-world practice.

What do the meta-analyses say?

The Cochrane review by Gupta et al. (7 trials, 793 women) compared embolisation with surgery (hysterectomy or myomectomy):

  • comparable satisfaction at 2 years and at 5 years;
  • no demonstrated difference in major complications;
  • more minor complications after embolisation;
  • fewer transfusions, a shorter procedure, a shorter hospital stay and a faster return to activities after embolisation;
  • a markedly higher risk of further surgery after embolisation: whereas 7% of women who had surgery need a repeat procedure at 2 years, this figure is estimated at between 15% and 32% after embolisation.

A meta-analysis published in AJOG in 2024 (6 randomised trials comparing embolisation and myomectomy) found a risk of repeat intervention about three times lower after myomectomy, with no difference in serious complications. When the analysis is limited to trials in which the surgery group included only myomectomies, quality of life is better after myomectomy. The authors consider the data on pregnancy after embolisation to be very uncertain.

How do the two options compare in practice?

CriterionMyomectomyUterine artery embolisation
Who performs itGynaecological surgeonInterventional radiologist
AnaesthesiaGeneral in most casesLocal with sedation
ScarDepending on the approach: none (hysteroscopy), small incisions (laparoscopy), abdominal incision (laparotomy)Puncture site in the groin or wrist
Hospital stayFrom day surgery (hysteroscopic route) to 3 to 5 days (laparotomy)Shorter than for surgery in published trials
Pain afterwardsScar pain, decreasingIntense pelvic pain in the first 24 to 48 hours, treated with strong painkillers
Return to activitiesSlower (especially after laparotomy)Faster
Fibroid removed and analysedYes, microscopic examinationNo, the fibroid stays in place and shrinks
Quality of life at 2 years (FEMME)BetterSlightly lower
Further interventionLess frequentMore frequent (15 to 32% at 2 years according to Cochrane)
TransfusionPossible, especially with multiple fibroidsRare
Pregnancy plansPreferred optionLimited data; not recommended as first-line
Ovarian reserveLittle affectedPossible reduction, especially after 45

Which option if you want a pregnancy?

This is the most decisive criterion. The Cochrane review presents embolisation as a safe, minimally invasive alternative to surgery for women who do not wish to become pregnant.

When a pregnancy is planned, myomectomy generally remains the preferred option:

  • a fibroid that distorts the cavity (types 0 to 2) is removed by hysteroscopy, without a scar on the muscle;
  • for other symptomatic fibroids, laparoscopy or laparotomy allows the fibroid to be removed, at the cost of a uterine scar that will need to be taken into account for the delivery.

Pregnancies are possible after embolisation, but data are scarce. In the Cochrane review, an analysis limited to a small subgroup suggested fewer births after embolisation than after myomectomy, with a very low level of evidence; the AJOG meta-analysis also considers these data very uncertain. Embolisation can therefore be discussed case by case, after full information, when surgery is considered too risky.

In which situations is fibroid embolisation particularly worthwhile?

  • a woman with no pregnancy plans who wishes to avoid surgery and general anaesthesia;
  • multiple fibroids, whose surgical removal would carry a risk of heavy bleeding;
  • a history of multiple abdominal operations or a contraindication to anaesthesia;
  • a wish to return to activities quickly;
  • refusal of blood transfusion.

It is less suitable, or even not advised, in the case of a pedunculated subserosal fibroid (risk of detachment), an intracavitary fibroid that can simply be removed by hysteroscopy, active pelvic infection, or doubt about the benign nature of the tumour, since the fibroid is not analysed.

How is the decision made?

The choice is based on a precise assessment, most often with a pelvic MRI: number, size, FIGO type and blood supply of the fibroids, and any associated adenomyosis. It takes into account:

  • the wish for pregnancy and age;
  • the predominant symptoms (bleeding, pressure, pain);
  • the patient’s priorities: quick recovery, avoiding surgery, or reducing the risk of further intervention;
  • the experience of the teams available.

The Cochrane review stresses the importance of patient selection and prior information. The decision is shared between the patient, the gynaecologist and the interventional radiologist, who performs the embolisation.

When should I seek urgent care?

After either treatment, seek medical advice promptly or call 15 (SAMU) or 112 in France, or your local emergency number, in the event of:

  • fever above 38.5 °C, especially with pelvic pain or foul-smelling discharge (infection of a necrotic fibroid after embolisation);
  • heavy bleeding;
  • pain that gets worse instead of better;
  • a growing bruise (haematoma) at the puncture site (groin or wrist);
  • feeling faint, breathlessness, pain in a calf.

Would you like a medical opinion?Appointments in Paris 16th or 5th, or by video consultation.

Book an appointment

Frequently asked questions

Does embolisation make the fibroid disappear completely?

No. The fibroid gradually shrinks over the following months, but stays in place. The aim is to reduce symptoms.

Can a myomectomy be performed after an embolisation that was not enough?

Yes, surgery is possible after failed embolisation. This is one of the reasons why repeat intervention rates are higher after embolisation.

Which treatment leads to the fewest serious complications?

Studies show no clear difference in major complications. Embolisation causes more minor complications, myomectomy more transfusions.

Does embolisation cause menopause?

Early menopause is possible, particularly after 45, because the procedure can reduce the blood supply to the ovaries. This risk is part of the information given beforehand.

Is embolisation reimbursed?

Uterine artery embolisation is a recognised procedure, covered by the Assurance maladie (French national health insurance) for its approved indications. The precise terms (any extra fees) should be checked with the team performing it. For a myomectomy, you are given a written estimate before the operation.

How long will I stay in hospital and be off work after embolisation or myomectomy?

As a rough guide: after embolisation, usually a day case to under 3 days in hospital, about 1 week off work and a return to sport after around 8 to 10 days; after laparoscopic myomectomy, 2 to 3 days and 2 to 4 weeks off work; after open surgery (laparotomy), 3 to 5 days and 4 to 6 weeks (6 to 8 for a physical job); after hysteroscopic myomectomy, a day case to under 3 days and 2 to 4 days off work. These guidelines are adapted to your situation at your consultation, and the time to wait before a pregnancy is discussed at the post-operative appointment.

References

Dr Olivier KadochObstetrician-gynaecologist and gynaecological surgeon in Paris, seeing patients in Paris 16th and at the Centre de la Femme Paris 5. Former chef de clinique-assistant (senior registrar) at the Paris public hospitals (AP-HP); individually accredited by the French National Authority for Health (HAS). RPPS 10003957809. Background and practice locations

A question about your situation?Appointments at the practice or by video consultation, usually within one week to 10 days.

Book an appointment

General information article: it does not replace a medical consultation. In an emergency, call 15 or 112 in France, or your local emergency number.